| Reference | Age/sex | Site | Immunophenotyping | Therapy | Outcome |
| Terasaki et al. [15] | 99/F | Pleural, pericardium | CD19, CD20, CD5, CD25, IgM, IgD | Drainage | Alive at 16 months | Wang et al. [16] | 79/M | Pleural | CD45, CD20, CD79a, bcl-2, bcl-6, MUM1 | Pleurodesis | Alive at 55 months | Terasaki et al. [15] | 85/M | Pleural, pericardium | CD20 | None | Alive at 11 months | Inoue et al. [17] | 67/F | Pericardium | CD20, CD79a | CHOP, MEPP, and DEVIC | Expired in 16 months | Kagoya et al. [18] | 74/M | Pericardium | CD20 | RCHOP | Expired in 7 months | Takahashi et al. [19] | 73/M | Pleural, pericardium, and peritoneum | CD20 | CHOP | Alive at 12 months |
Terasaki et al. [20] | 68/M | Pleural | CD20, CD79a | RCHOP | Alive at 22 months | Fujisawa et al. [21] | 69/M | Pleural, pericardium | CD19, CD20, CD5, bcl2, Cyclin D1 | THP-COP | Expired in 5 months | Youngster et al. [22] | 88/M | Pleural | CD20, CD30, CD79a, CD45 | RCHOP | Alive at 11 months | Hermine et al. [11] | 52/F | Pleural, pericardium | CD19, CD20, CD22, CD45, HLA-DR | Not mentioned | Not mentioned | Ohshima et al. [14] | 75/M | Pleural | CD19, CD20, HLA-DR | CHOP | Expired in 15 months | Ohshima et al.* [14] | 76/M | Pleural | CD19, CD20, CD10, HLA-DR | None | Alive at 6 months | Ohshima et al.* [14] | 32/F | Peritoneum | CD10, CD19, CD20, HLA-DR | CHOP and PBSCT | Alive at 13 months | Ohshima et al.* [14] | 81/M | Pleural | CD19, CD20, CD10, CD5, HLA-DR | None | Alive at 2 months | Shimazaki et al. [23] | 90/F | Pleural, pericardium, and peritoneum | CD20, CD79a, BCL-2 | None | Expired in five months |
Inoue et al. [24] | 70/F | Pleural, pericardium | CD19, CD20, CD22, CD24, CD8, CD10, CD38, HLA DR | CHOP and sobuzoxane | Alive at 30 months | Fujiwara et al. [25] | 75/F | Pericardium | CD20, CD79a | CHOP | Alive at 36 months | Nemr et al.* [26] | 92/F | Pleural | CD20, CD45, BCL-2 | None | Expired in 2 months | Nakamura et al. [27] | 51/M | Scrotum | CD45, CD19, CD20, CD79a | Carboplatin, etoposide, mitoxantrone, prednisone, and RT | Alive at 8 months | Saini et al. [28] | 87/F | Pleural | CD19, CD45, CD20, CD79a | Pleurodesis | Alive at 21 months | Saini et al. [28] | 82/F | Pleural | CD20, bcl6, MUM1, PAX 5 | Pleural drainage | Expired in 13 months | Matsumoto et al. [29] | 90/M | Pleural | CD19, CD20, CD30 | R + THP-COP | Alive at 38 months | Matsumoto et al. [29] | 87/F | Pleural | CD20, CD30 | Rituximab | Alive at 32 months | Our patient | 76/M | Pleural/pericardium | CD-20, CD-10, BCL-2, MIB 1 | None | Alive at 14 months |
|
|